Gulrayz Ahmed
-
- CAR-T cell therapy research 6
- Pancreatic and Hepatic Oncology Research 4
-
- CNS Lymphoma Diagnosis and Treatment 4
-
- Acute Lymphoblastic Leukemia research 4
-
- Cancer Genomics and Diagnostics 4
-
- Lymphoma Diagnosis and Treatment 4
-
- Acute Myeloid Leukemia Research 3
- Hematopoietic Stem Cell Transplantation 3
- Co-authors
- Mehdi HamadaniNirav N. ShahMustafa AbbasSherry‐Ann BrownPippa SimpsonZahid MemonDavid L. JoyceLucian A. Durham
- Partner nations
- United StatesPakistanCanada
In The Last Decade
Gulrayz Ahmed
24 papers receiving 177 citations
Peers
Comparison fields: 5 of 52
- Pharmacy 14
- Emergency Medicine 27
- Internal Medicine 9
- Oncology 58
- Neurology 25
Countries citing papers authored by Gulrayz Ahmed
This map shows the geographic impact of Gulrayz Ahmed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gulrayz Ahmed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gulrayz Ahmed more than expected).
Fields of papers citing papers by Gulrayz Ahmed
This network shows the impact of papers produced by Gulrayz Ahmed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gulrayz Ahmed. The network helps show where Gulrayz Ahmed may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gulrayz Ahmed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 9 | |
| 12 | 2021 | 41 | |
| 13 | 2021 | 44 | |
| 14 | 2021 | 1 | |
| 15 | 2020 | 5 | |
| 16 | 2020 | 8 | |
| 17 | 2017 | 8 | |
| 18 | 2017 | 3 | |
| 19 | 2013 | 23 | |
| 20 | 2012 | 14 |
About Gulrayz Ahmed
Gulrayz Ahmed is a scholar working on Internal Medicine, Oncology and Hematology, having authored 27 papers that have together received 179 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Cancer Genomics and Diagnostics (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Acute Myeloid Leukemia Research (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). The work is most often cited by research in Pharmacy (14 citations), Emergency Medicine (27 citations) and Internal Medicine (9 citations). Gulrayz Ahmed has collaborated with scholars based in United States, Pakistan and Canada. Frequent co-authors include Mehdi Hamadani, Nirav N. Shah, Mustafa Abbas, Sherry‐Ann Brown, Pippa Simpson, Zahid Memon, David L. Joyce, Lucian A. Durham, Dong Wang and Kathryn T. Hall. Their work appears in journals such as Journal of Clinical Oncology, Blood and BMC Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.